Anti-Mouse CD3 (17A2) – Purified (PhenoCyler-Fusion (CODEX)® Ready)
Anti-Mouse CD3 (17A2) – Purified (PhenoCyler-Fusion (CODEX)® Ready)
Product No.: C2460
- -
- -
Clone 17A2 Target CD3 Formats AvailableView All Product Type Recombinant Monoclonal Antibody Alternate Names T-cell Receptor Complex, CD3ε Isotype Rat IgG2b κ Applications Costim , FA , FC , IF , IHC FF , IP , PhenoCycler® |
- -
- -
CODEX® DetailsValidation Notes Clone 17A2 has been validated for use on CODEX® using mouse spleen fresh frozen (FF) tissue. Tissue Screened Spleen Tissue Preparation FF (Fresh Frozen) Antibody and Reporter DetailsReactivity Species Mouse Host Species Rat Concentration 0.5 mg/ml Immunogen γ/δ TCR-positive T-T hybridoma D1 Formulation This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4. Product Preparation Recombinant antibodies are manufactured in an animal free facility using only <i>in vitro</i> protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling This antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Applications and Recommended Usage? Quality Tested by Leinco CODEX® This CD3 (Clone 17A2) antibody is formulated to simplify the antibody preparation needed when performing a CODEX® barcode conjugate. The suggested concentration is 0.5 mg/ml. Other Applications Reported In Literature ? PhenoCycler-Fusion (CODEX)® FA2,3,5,6 Depletion2,4,5 IP6 RIA6 FC IHC (Frozen) The suggested concentration for this 17A2 antibody in IHC staining on frozen tissue is 5.0 - 10 μg per ml. Titration of the reagent is recommended for optimal performance for each application. RRID AB_2893570 Country of Origin USA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity 17A2 activity is directed against the mouse TCR ⍺β- and TCR γ?-associated
CD3 molecular complex via the CD3ε chain. Antigen Distribution CD3 is expressed on T cells. Background CD3 is an invariant antigen of the T cell receptor (TCR) 1. The CD3/TCR complex is composed of a ⍺β or γ? TCR heterodimer noncovalently associated with invariant CD3 dimers ?γ, ??, and ?? in a 1:1:1:1 stoichiometry. The TCR mediates recognition of antigenic peptides bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells, while the CD3 portion of the complex transduces activation signals to the T cell nucleus. Together, TCR and CD3 molecules initiate protective immunity against microbes and cancers.
17A2 has been explored as a treatment against graft-versus-host disease 2,3. 17A2 leads to T cell depletion in vivo that is associated with a significant reduction in B cell population 4. Additionally, 17A2 is less mitogenic that some other anti-CD3 antibodies (i.e., 145-2C11 hamster IgG and KT3 rat IgG2a) 3. FcγRI may be involved in 17A2 activity 5. 17A2 was generated by immunizing female Sprague-Dawley rats with homogenized γ? TCR+ T-T hybridoma cells (D1 line) 6. The resulting rat cells were fused to P3X63-Ag8-653 non-secreting mouse myeloma cells and hybridomas were screened for the secretion of IL-2 in the presence of D1 cells. Antigen DetailsProtein Ligand/Receptor Peptide antigen/MHC-complex Function Antigen recognition, TCR signal transduction, T cell activation PubMed NCBI Gene Bank ID UniProt.org References & Citations1. Mariuzza RA, Agnihotri P, Orban J. J Biol Chem. 295(4):914-925. 2020. 2. Mysliwietz J, Thierfelder S. Blood. 80(10):2661-2667. 1992. 3. Vossen AC, Tibbe GJ, Kroos MJ, et al. Eur J Immunol. 25(6):1492-1496. 1995. 4. Loubaki L, Tremblay T, Bazin R. J Immunol Methods. 393(1-2):38-44. 2013. 5. Kummer U, Zengerle U, Pischel J, et al. Immunol Lett. 75(2):153-158. 2001. 6. Miescher GC, Schreyer M, MacDonald HR. Immunol Lett. 23(2):113-118. 1989. Technical Protocols |
Related Products
- -
- -
Prod No. | Description |
---|---|
S211 | |
R1364 | |
I-1034 | |
C247 | |
F1175 | |
R1214 | |
S571 |
Formats Available
